XML 110 R5.htm IDEA: XBRL DOCUMENT v3.24.2
Consolidated Statements of Changes in Stockholders' Deficit - USD ($)
Common Class A [Member]
Common Stock [Member]
Common Class B [Member]
Common Stock [Member]
Common Stock [Member]
Reverse Recapitalization [Member]
Additional Paid-in Capital [Member]
Additional Paid-in Capital [Member]
Reverse Recapitalization [Member]
Retained Earnings [Member]
Retained Earnings [Member]
Reverse Recapitalization [Member]
Total
Reverse Recapitalization [Member]
Series A Preferred Stock [Member]
Preferred Stock [Member]
Reverse Recapitalization [Member]
Series B Preferred Stock [Member]
Preferred Stock [Member]
Reverse Recapitalization [Member]
Balance at Dec. 31, 2021 $ 145 $ 1,198     $ (14,229,052)   $ (14,227,709)      
Balance, shares at Dec. 31, 2021 1,450,000 11,983,333                  
Accretion of carrying value to redemption value     (4,964,000)   (4,964,000)      
Net Income (loss)     4,408,361   4,408,361      
Balance at Dec. 31, 2022 $ 145 $ 1,198 $ 12,000 $ 5,216,840 (14,784,691) $ (39,180,057) (14,783,348) $ (33,951,217)
Balance, shares at Dec. 31, 2022 1,450,000 11,983,333 119,999,989            
Net Income (loss)         (30,756,144) (30,756,144) (30,756,144)
Balance at Mar. 31, 2023     $ 12,000   5,216,840   (69,936,201)   (64,707,361)
Balance, shares at Mar. 31, 2023     119,999,989            
Balance at Dec. 31, 2022 $ 145 $ 1,198 $ 12,000 5,216,840 (14,784,691) (39,180,057) (14,783,348) (33,951,217)
Balance, shares at Dec. 31, 2022 1,450,000 11,983,333 119,999,989            
Conversion of convertible promissory notes into common stock in connection with merger $ 1,198 $ (1,198)            
Conversion of convertible promissory notes into common stock in connection with merger, shares 11,983,333 (11,983,333)                  
Proceeds allocated to Class A shares issuable from the note payable   275,306     275,306      
Accretion of carrying value to redemption value   (275,306)   (2,526,621)   (2,801,927)      
Net Income (loss)     (67,325)   (67,325)      
Balance at Dec. 31, 2023 $ 1,343 $ 12,000 5,216,840 $ (17,378,637) (99,657,737) (17,377,294) (94,428,897)
Balance, shares at Dec. 31, 2023 13,433,333 119,999,989            
Conversion of convertible promissory notes into common stock in connection with merger     $ 1,034   46,621,593     46,622,627
Conversion of convertible promissory notes into common stock in connection with merger, shares     10,337,419                
Net Income (loss)         11,264,842 $ 11,264,842 11,264,842
Issuance of Series A preferred stock           2,799,990 $ 2,799,990
Issuance of Series A preferred stock, shares               164,614,418   500  
Nonrefundable prepaid proceeds towards anticipated Series A-1 preferred stock issuance       200,000     200,000
Issuance of Series B preferred stock           3,613,000 $ 3,613,000
Issuance of Series B preferred stock, shares                     3,613
Merger, net of redemptions and transaction costs     $ 1,478   (2,885,459)     (2,883,981)
Merger, net of redemptions and transaction costs, shares     14,778,056              
Issuance of restricted common stock     $ 1,935   (1,935)    
Issuance of restricted common stock, shares     19,348,954                
Issuance of common stock for Sponsor advisory service fee     $ 15   676,485     676,500
Issuance of common stock for Sponsor advisory service fee, shares     150,000                
Stock-based compensation       26,333,249     26,333,249
Balance at Mar. 31, 2024     $ 16,462   $ 76,160,773   $ (88,392,895) $ (5,802,670) $ (5,802,670) $ 2,799,990 $ 3,613,000
Balance, shares at Mar. 31, 2024     164,614,418             500 3,613